Literature DB >> 20378863

Underestimation of cognitive impairment by Mini-Mental State Examination versus the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke: a population-based study.

Sarah T Pendlebury1, Fiona C Cuthbertson, Sarah J V Welch, Ziyah Mehta, Peter M Rothwell.   

Abstract

BACKGROUND AND
PURPOSE: The Mini-Mental State Examination (MMSE) is insensitive to mild cognitive impairment and executive function. The more recently developed Montreal Cognitive Assessment (MoCA), an alternative, brief 30-point global cognitive screen, might pick up more cognitive abnormalities in patients with cerebrovascular disease.
METHODS: In a population-based study (Oxford Vascular Study) of transient ischemic attack and stroke, the MMSE and MoCA were administered to consecutive patients at 6-month or 5-year follow-up. Accepted cutoffs of MMSE <27 and MoCA <26 were taken to indicate cognitive impairment.
RESULTS: Of 493 patients, 413 (84%) were testable. Untestable patients were older (75.5 versus 69.9 years, P<0.001) and often had dysphasia (24%) or dementia (15%). Although MMSE and MoCA scores were highly correlated (r(2)=0.80, P<0.001), MMSE scores were skewed toward higher values, whereas MoCA scores were normally distributed: median and interquartile range 28 (26 to 29) and 23 (20 to 26), respectively. Two hundred ninety-one of 413 (70%) patients had MoCA <26 of whom 162 had MMSE > or =27, whereas only 5 patients had MoCA > or =26 and MMSE <27 (P<0.0001). In patients with MMSE > or =27, MoCA <26 was associated with higher Rankin scores (P=0.0003) and deficits in delayed recall, abstraction, visuospatial/executive function, and sustained attention.
CONCLUSIONS: The MoCA picked up substantially more cognitive abnormalities after transient ischemic attack and stroke than the MMSE, demonstrating deficits in executive function, attention, and delayed recall.

Entities:  

Mesh:

Year:  2010        PMID: 20378863     DOI: 10.1161/STROKEAHA.110.579888

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  124 in total

1.  Evaluation of a Brief Survey Instrument for Assessing Subtle Differences in Cognitive Function Among Older Adults.

Authors:  Ashwin A Kotwal; Philip Schumm; David W Kern; Martha K McClintock; Linda J Waite; Joseph W Shega; Megan J Huisingh-Scheetz; William Dale
Journal:  Alzheimer Dis Assoc Disord       Date:  2015 Oct-Dec       Impact factor: 2.703

2.  Brief Memory and Executive Test: evaluation of a new screening test for cognitive impairment due to small vessel disease.

Authors:  Rebecca L Brookes; Kristin Hannesdottir; Robert Lawrence; Robin G Morris; Hugh S Markus
Journal:  Age Ageing       Date:  2012-01-19       Impact factor: 10.668

3.  Longitudinal Change in Performance on the Montreal Cognitive Assessment in Older Adults.

Authors:  Sarah A Cooley; Jodi M Heaps; Jacob D Bolzenius; Lauren E Salminen; Laurie M Baker; Staci E Scott; Robert H Paul
Journal:  Clin Neuropsychol       Date:  2015-09-16       Impact factor: 3.535

4.  Co-occurrence of parkinsonism and dementia in clinical practice: relevant differential diagnoses.

Authors:  I Liepelt-Scarfone; M Jamour; W Maetzler
Journal:  Z Gerontol Geriatr       Date:  2012-01       Impact factor: 1.281

5.  Pulsatile versus non-pulsatile flow to reduce cognitive decline after coronary artery bypass surgery: A randomized prospective clinical trial.

Authors:  Koray Aykut; Gokhan Albayrak; Mehmet Guzeloglu; Eyup Hazan; Muge Tufekci; Ipek Erdoğan
Journal:  J Cardiovasc Dis Res       Date:  2013-06-18

Review 6.  The relationship between blood pressure and cognitive function.

Authors:  Vera Novak; Ihab Hajjar
Journal:  Nat Rev Cardiol       Date:  2010-10-26       Impact factor: 32.419

7.  Normative Data for the Montreal Cognitive Assessment in Middle-Aged and Elderly Quebec-French People.

Authors:  Eddy Larouche; Marie-Pier Tremblay; Olivier Potvin; Sophie Laforest; David Bergeron; Robert Laforce; Laura Monetta; Linda Boucher; Pascale Tremblay; Sylvie Belleville; Dominique Lorrain; Jean-François Gagnon; Nadia Gosselin; Christian-Alexandre Castellano; Stephen C Cunnane; Joël Macoir; Carol Hudon
Journal:  Arch Clin Neuropsychol       Date:  2016-11-22       Impact factor: 2.813

Review 8.  Antihypertensive treatment can prevent stroke and cognitive decline.

Authors:  Peter Sörös; Shawn Whitehead; J David Spence; Vladimir Hachinski
Journal:  Nat Rev Neurol       Date:  2012-12-18       Impact factor: 42.937

9.  Predictive value of MoCA in the acute phase of stroke on the diagnosis of mid-term cognitive impairment.

Authors:  Emilia Salvadori; Marco Pasi; Anna Poggesi; Guido Chiti; Domenico Inzitari; Leonardo Pantoni
Journal:  J Neurol       Date:  2013-05-29       Impact factor: 4.849

10.  Hypertension and mild cognitive impairment.

Authors:  Cristina Sierra; Mónica Doménech; Miguel Camafort; Antonio Coca
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.